Sanj K. Patel - 01 Jun 2026 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Jun 2026, 16:50:02 UTC
Prior SEC filing
01 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Douglas Barry, Attorney-in-Fact

Key filing fact

Sanj K. Patel filed Form 4 for Kiniksa Pharmaceuticals International, plc (KNSA) on 02 Jun 2026.

Key facts

  • This page summarizes Sanj K. Patel's Form 4 filing for Kiniksa Pharmaceuticals International, plc (KNSA).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 02 Jun 2026, 16:50.

Change

  • Previous filing in this sequence was filed on 01 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001532218 Primary reporting owner

Patel Sanj K

Relationship
CHAIRMAN & CEO, Director
Address
C/O KINIKSA PHARMACEUTICALS INT'L, 105 PICCADILLY, SECOND FLOOR, LONDON, UNITED KINGDOM
Signature
/s/ Douglas Barry, Attorney-in-Fact
Signature date
02 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KNSA transaction

Class A Ordinary Share

Conversion of derivative security

Transaction value
Shares
+900,000
Change %
+1738%
Price
Shares after
951,794
Date
01 Jun 2026
Ownership
The Anglia 2013 Revocable Trust
Footnotes
F1
KNSA holding

Class A Ordinary Share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
109,795
Date
01 Jun 2026
Ownership
Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016
KNSA holding

Class A Ordinary Share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
76,174
Date
01 Jun 2026
Ownership
Held by The Patel Family Irrevocable Trust of 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KNSA transaction Derivative

Class B Ordinary Shares

Conversion of derivative security

Transaction value
Shares
-900,000
Change %
-59%
Price
$0.000000*
Shares after
626,160
Date
01 Jun 2026
Ownership
The Anglia 2013 Revocable Trust
Underlying class
Class A Ordinary Share
Underlying amount
900,000
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each share of Class B Ordinary Shares is convertible at any time at the election of the holder, subject to certain contractual arrangements entered into between the Reporting Person and the Issuer, into one share of Class A Ordinary Shares or one share of Class B1 Ordinary Shares and will automatically convert into Class A Ordinary Shares upon transfer to an unaffiliated party.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .